• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1969 - 2002年阿肯色州胰腺癌死亡率的模式与趋势:与美国总体人口的比较

Patterns and trends of pancreatic cancer mortality rates in Arkansas, 1969-2002: a comparison with the US population.

作者信息

Zhang Jianjun, Dhakal Ishwori, Ning Baitang, Kesteloot Hugo

机构信息

Department of Epidemiology, Fay W. Boozman College of Public Health, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, USA.

出版信息

Eur J Cancer Prev. 2008 Feb;17(1):18-27. doi: 10.1097/CEJ.0b013e32809b4ccd.

DOI:10.1097/CEJ.0b013e32809b4ccd
PMID:18090906
Abstract

Little is known about trends in pancreatic cancer mortality in individual states of the US and its whole population. This study aimed to describe the patterns and trends of pancreatic cancer mortality in Arkansas, 1969-2002, using the US national rates as a reference. Joinpoint regression analyses were performed to evaluate trends in age-standardized mortality rates of pancreatic cancer by age group, sex, and race, using data obtained from the National Center for Health Statistics. Throughout the period examined, mortality decreased in young and middle-aged people (<60 years) and men but increased in old people (>/=60 years) and women. A continuous fall in mortality occurred among whites except for a transient rise in the late 1970s. For blacks, mortality rates did not cease to increase until 1995. Unlike in Arkansas, a monotonic upward or downward trend in mortality by age group and sex was not observed in the US. A decline of mortality stopped in 1997 for US whites. Recent decreasing trends were more pronounced in Arkansas blacks than in US blacks. Changes of pancreatic cancer mortality in the last three decades in Arkansas remarkably differed by age, sex, and race and were different in patterns from those of the US population.

摘要

关于美国各州以及全体人口的胰腺癌死亡率趋势,人们了解甚少。本研究旨在以美国全国死亡率为参照,描述1969年至2002年阿肯色州胰腺癌死亡率的模式和趋势。利用从美国国家卫生统计中心获取的数据,进行连接点回归分析,以评估按年龄组、性别和种族划分的胰腺癌年龄标准化死亡率趋势。在整个研究期间,年轻和中年人群(<60岁)以及男性的死亡率下降,而老年人群(≥60岁)和女性的死亡率上升。除了20世纪70年代末有短暂上升外,白人的死亡率持续下降。对于黑人,死亡率直到1995年才停止上升。与阿肯色州不同,在美国未观察到按年龄组和性别划分的死亡率呈单调上升或下降趋势。美国白人的死亡率下降在1997年停止。最近阿肯色州黑人的下降趋势比美国黑人更明显。过去三十年阿肯色州胰腺癌死亡率的变化在年龄、性别和种族方面显著不同,且模式与美国总体人群不同。

相似文献

1
Patterns and trends of pancreatic cancer mortality rates in Arkansas, 1969-2002: a comparison with the US population.1969 - 2002年阿肯色州胰腺癌死亡率的模式与趋势:与美国总体人口的比较
Eur J Cancer Prev. 2008 Feb;17(1):18-27. doi: 10.1097/CEJ.0b013e32809b4ccd.
2
Mortality from lung cancer and tobacco smoking in Ohio (U.S.): will increasing smoking prevalence reverse current decreases in mortality?美国俄亥俄州肺癌死亡率与吸烟情况:吸烟率上升会扭转当前死亡率下降的趋势吗?
Cancer Epidemiol Biomarkers Prev. 2005 May;14(5):1182-7. doi: 10.1158/1055-9965.EPI-04-0699.
3
Temporal trends in breast cancer mortality by state and race.按州和种族划分的乳腺癌死亡率的时间趋势。
Cancer Causes Control. 2008 Jun;19(5):537-45. doi: 10.1007/s10552-008-9113-1. Epub 2008 Feb 13.
4
Colorectal cancer incidence in the United States, 1999-2004 : an updated analysis of data from the National Program of Cancer Registries and the Surveillance, Epidemiology, and End Results Program.1999 - 2004年美国结直肠癌发病率:来自国家癌症登记计划和监测、流行病学及最终结果计划数据的更新分析
Cancer. 2009 May 1;115(9):1967-76. doi: 10.1002/cncr.24216.
5
The epidemiology of pancreatic cancer in the United States: changes below the surface.美国胰腺癌的流行病学:表象之下的变化
Aliment Pharmacol Ther. 2006 Jul 1;24(1):87-94. doi: 10.1111/j.1365-2036.2006.02961.x.
6
Pancreatic cancer in England and Wales 1975-2000: patterns and trends in incidence, survival and mortality.1975 - 2000年英格兰和威尔士的胰腺癌:发病率、生存率和死亡率的模式与趋势
Aliment Pharmacol Ther. 2006 Apr 15;23(8):1205-14. doi: 10.1111/j.1365-2036.2006.02860.x.
7
Trends in unintentional injury deaths, U.S., 1999-2005: age, gender, and racial/ethnic differences.1999 - 2005年美国非故意伤害死亡趋势:年龄、性别及种族/族裔差异
Am J Prev Med. 2009 Sep;37(3):188-94. doi: 10.1016/j.amepre.2009.04.023.
8
Interpreting trends of pancreatic cancer incidence and mortality: a nation-wide study in Sweden (1960-2003).解读胰腺癌发病率和死亡率趋势:瑞典全国性研究(1960 - 2003年)
Cancer Causes Control. 2008 Feb;19(1):89-96. doi: 10.1007/s10552-007-9073-x. Epub 2007 Oct 18.
9
Contemporary lung cancer trends among U.S. women.美国女性当代肺癌趋势
Cancer Epidemiol Biomarkers Prev. 2005 Mar;14(3):582-5. doi: 10.1158/1055-9965.EPI-04-0554.
10
Decreasing mortality from pulmonary embolism in the United States, 1979-1996.1979 - 1996年美国肺栓塞死亡率的下降
Int J Epidemiol. 2000 Jun;29(3):465-9.

引用本文的文献

1
Pancreatic Tumorigenesis: Precursors, Genetic Risk Factors and Screening.胰腺肿瘤发生:前体、遗传风险因素和筛查。
Curr Oncol. 2022 Nov 15;29(11):8693-8719. doi: 10.3390/curroncol29110686.
2
From Screening to Treatment of Pancreatic Cancer: A Comprehensive Review.从胰腺癌的筛查到治疗:全面综述
JOP. 2021;22(3):70-79. Epub 2021 May 31.
3
Current controversies and advances in the management of pancreatic adenocarcinoma.胰腺腺癌治疗中的当前争议与进展
World J Gastrointest Oncol. 2021 Jun 15;13(6):472-494. doi: 10.4251/wjgo.v13.i6.472.
4
Extended lymph node resection versus standard resection for pancreatic and periampullary adenocarcinoma.胰头和壶腹周围腺癌的扩大淋巴结清扫与标准清扫。
Cochrane Database Syst Rev. 2021 Jan 20;1(1):CD011490. doi: 10.1002/14651858.CD011490.pub2.
5
The accuracy of sentinel node biopsy by Tc-sodium phytate in patients with pancreatic cancer.植酸钠锝在胰腺癌患者中进行前哨淋巴结活检的准确性。
Ann Hepatobiliary Pancreat Surg. 2020 Aug 31;24(3):277-282. doi: 10.14701/ahbps.2020.24.3.277.
6
Expression of phosphorylated estrogen receptor beta is an independent negative prognostic factor for pancreatic ductal adenocarcinoma.磷酸化雌激素受体β的表达是胰腺导管腺癌的一个独立的预后不良因素。
J Cancer Res Clin Oncol. 2018 Oct;144(10):1887-1897. doi: 10.1007/s00432-018-2717-2. Epub 2018 Jul 25.
7
The impact of a history of cancer on pancreatic ductal adenocarcinoma survival.癌症病史对胰腺导管腺癌生存率的影响。
United European Gastroenterol J. 2018 Jul;6(6):888-894. doi: 10.1177/2050640618765505. Epub 2018 Apr 30.
8
Update on the role of nanoliposomal irinotecan in the treatment of metastatic pancreatic cancer.纳米脂质体伊立替康在转移性胰腺癌治疗中作用的最新进展
Therap Adv Gastroenterol. 2017 Jul;10(7):563-572. doi: 10.1177/1756283X17705328. Epub 2017 Apr 26.
9
Genetic factors affecting patient responses to pancreatic cancer treatment.影响患者对胰腺癌治疗反应的遗传因素。
Ann Gastroenterol. 2016 Oct-Dec;29(4):466-476. doi: 10.20524/aog.2016.0056. Epub 2016 Jun 10.
10
Evaluation of Serum Interleukin-17 (IL-17) Levels as a Diagnostic Marker in Pancreatic Adenocarcinoma.评估血清白细胞介素-17(IL-17)水平作为胰腺腺癌诊断标志物的研究
J Gastrointest Cancer. 2016 Mar;47(1):47-54. doi: 10.1007/s12029-015-9787-z.